Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
342
datasets available to search
ShareScore release 0.9.0
Dataset results
342 results for “biliary tract”
Phase I Study of Gemcitabine or S-1 Adjuvant Therapy After Hemihepatectomy for Biliary Tract Cancer
ClinicalTrials.gov study NCT01291615. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Pressurized Intraperitoneal Aerosolized Nab-Paclitaxel in Combination With Gemcitabine and Cisplatin for the Treatment of Biliary Tract Cancer Patients With Peritoneal Metastases
ClinicalTrials.gov study NCT05285358. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study of S-1 in Combination With Gemcitabine as First-Line Treatment in Patients With Advanced Biliary Tract Cancer
ClinicalTrials.gov study NCT02425137. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Cetuximab + Gemox in Biliary Tract Cancer
ClinicalTrials.gov study NCT01216345. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Trastuzumab-pkrb Combined With Modified FOLFOX-6 in Biliary Tract Cancer Patients Progressed on First Line Therapy
ClinicalTrials.gov study NCT04722133. IPD Sharing: NO. Countries: 1. Publications: 1.
Anlotinib Plus Nab-Paclitaxels and S-1 for Patients with Advanced Biliary Tract Cancer As Second-Line Treatment
ClinicalTrials.gov study NCT06662877. IPD Sharing: NO. Countries: 1. Publications: 12.
Panitumumab Plus Gemcitabine and Oxaliplatin (GEMOX)Versus GEMOX Alone to Treat Advanced Biliary Tract Adenocarcinoma
ClinicalTrials.gov study NCT01389414. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Trial of S-1 Plus Cisplatin (SP) Versus Gemcitabine Plus Cisplatin (GP) in Advanced Biliary Tract Adenocarcinoma
ClinicalTrials.gov study NCT01375972. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Cell-free DNA Methylation Blood-Based Test for Biliary Tract Cancers Screening
ClinicalTrials.gov study NCT07176962. IPD Sharing: UNDECIDED. Countries: 1. Publications: 4.
Safety of Biliary Intraductal Radiofrequency Ablation in Patients With Unresectable Extrahepatic Biliary Tract Cancer
ClinicalTrials.gov study NCT06274879. IPD Sharing: NO. Countries: 1. Publications: 2.
Adjuvant Chemotherapy Regimens in Resected Biliary Tract Cancers (TOG/GI-SAFRADJU-2501)
ClinicalTrials.gov study NCT06975917. IPD Sharing: NO. Countries: 1. Publications: 0.
Gemcitabine With or Without Cisplatin in Treating Patients With Unresectable Locally Advanced or Metastatic Cholangiocarcinoma or Other Biliary Tract Tumors
ClinicalTrials.gov study NCT00262769. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Population-Based Case-Control Study of Biliary Tract Cancers in Shanghai, China
ClinicalTrials.gov study NCT00339560. IPD Sharing: Not stated. Countries: 1. Publications: 3.
Toripalimab Plus Lenvatinib as Second-line Treatment in Advanced Biliary Tract Cancers
ClinicalTrials.gov study NCT04211168. IPD Sharing: Not stated. Countries: 1. Publications: 22.
Lenvatinib in Patients With Previously Treated Advanced Biliary Tract Cancer
ClinicalTrials.gov study NCT04656249. IPD Sharing: NO. Countries: 1. Publications: 22.
Trial of Infusional FOLFIRINOX in First Line Treatment of Advanced Biliary Tract Cancers
ClinicalTrials.gov study NCT03291899. IPD Sharing: NO. Countries: 1. Publications: 2.
mFOLFOX vs. mFOLFIRI in Advanced or Recurrent Biliary Tract Cancer Refractory to First Line
ClinicalTrials.gov study NCT03464968. IPD Sharing: NO. Countries: 1. Publications: 1.
Fluorouracil, Cisplatin, and Radiation Therapy or Gemcitabine and Oxaliplatin in Treating Patients With Nonmetastatic Biliary Tract Cancer That Cannot Be Removed By Surgery
ClinicalTrials.gov study NCT00304135. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study to Select a Dose Regimen (Part A) and to Investigate Overall Survival (Part B) With Nanvuranlat Compared With Physician's Best Choice in Participants Aged 18 Years or Older With Biliary Tract
ClinicalTrials.gov study NCT07265674. IPD Sharing: UNDECIDED. Countries: 1. Publications: 1.
COmbination of Radiotherapy With Anti-PD-1 Antibody for unREseCtable Biliary Tract Cancer
ClinicalTrials.gov study NCT03898895. IPD Sharing: NO. Countries: 1. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.